JAVELIN Lung 100: updated design of a phase 3 trial of aveiumab vs platinum doublet chemotherapy as first-line (1L) treatment for metastatic or recurrent PD-L1+non-small-cell lung cancer (NSCLC)
Author
Yang, C-H.
Dols, M. Cobo
Skuladottir, H.
Park, K.
Sullivan, R.
Veatch, A. L.
Pavlakis, N.
Dreosti, L. M.
Morgillo, F.
Schlichting, M.
Teofilovici, F.
Chand, V.
Westeel, V.
Ozguroglu, M.
Kim, T. M.
Reck, M.
Thomas, M.
Font, E. F.
Barlesi, F.
Postmus, P. E.
Metadata
Show full item recordCollections
- Bildiri [64839]